Article and Video CATEGORIES

Cancer Journey

Search By

Carlea has over 20 years of experience in nonprofit management and health advocacy. In October 2013, she joined The Global Resource for Advancing Cancer Education as its first executive director. She directs its growth in revenue, outreach and programs.

30 Days of Thanks and Lung Cancer

November is a month of gratitude in the U.S. It is also Lung Cancer Awareness Month (LCAM). Cancer patients have a unique perspective on gratitude, so it is only fitting that we combine them for our second LCAM Gratitude Campaign.

Each day this month, through a series of videos and photos, you'll meet lung cancer patients and their families who find joy in the little things (like cupcakes) and big things (like cancer research). Most of the campaign will happen on social media – on our Twitter, Facebook, YouTube, and Instagram feeds – so be sure to follow us on at least one of those platforms, where we hope you'll also share your own photos or thoughts on gratitude.

Along the way, we'll provide information about lung cancer treatments - both currently available options and discussions about what may or may not be on the horizon - that patients can take to their doctors. We encourage you to share it with the lung cancer patients and caregivers in your life so that they can benefit from it as well.

To kick off the gratitude, we would like to thank Keith Singer at Catch It in Time, who produced the videos, to Gilles Frydman and Laya Dogmetchi who took the portraits you will see throughout the month, to the patients and caregivers who stepped in front of our cameras with open and grateful hearts, and to you, the people who visit the GRACE website and read our materials on a regular basis. Thank you for appreciating our work.

 

And thanks to the following companies for their support of our LCAM 2016 program

Celgene 2015B-I for weblargeLilly redgenentech-logo-750

 

 

Next Previous link

Previous PostNext Post

Related Content

Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Recent Comments

JOIN THE CONVERSATION
Yes, it's crucial to discuss…
By JanineT GRACE … on
Definitely a good idea to…
By OakleeFarnick on
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on